Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.24.3
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Net Loss per Share [Abstract]  
Schedule of Diluted Net Loss Per Share The following securities were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:
    For the three months ended  
    March 31,  
    2024     2023  
Stock options     3,333       7,889  
Warrants     9,101       103,069  
Restricted stock units     163,996       182,562  
Total common stock equivalents     176,430       293,520